Robert J. Carpenter
Co-Founder & Chair EmeritusMr. Robert J. Carpenter, also known as Bob, M.S., M.B.A., is Director of Aquinnah Pharmaceuticals, Inc. Mr. Carpenter Co-Founded Immuneering Corporation in 2008 and served as its Independent Chairman and has been its director since May 2009. He serves as the President of Boston Medical Investors, Inc. He serves as Chair Emeritus at Immuneering Corporation. From 1992 until 2015, he served as the Chief Executive Officer of Boston Medical Investors, Inc. Mr. Carpenter serves as Chief Executive Officer at Rec, Inc. He serves as Managing Director at CMA. Mr. Carpenter is Founder of Lysosomal Therapeutics Inc. and serves as its Chairman. He served as President and Chief Executive Officer of VacTex, Inc. from November 1995 to April 1998. Mr. Carpenter served as President, Chief Executive Officer and Chairman at Peptimmune, Inc. From 1989 to 1991, He served as Executive Vice President and Chief Executive Officer at Genzyme Corporation. Mr. Carpenter served as Chief Executive Officer and Chairman of the Board of IG Laboratories, Inc. from 1989 to 1991 and its Executive Vice President until 1991. He co-founded GelTex Pharmaceuticals, Inc. in November 1991. Mr. Carpenter served as President and Chief Executive Officer of GelTex Pharmaceuticals Inc. from 1991 to May 1993. From 1981 to 1989, he served as President, Chief Executive Officer and Chairman of Integrated Genetics, Inc. Mr. Carpenter founded and led several companies, such as VacTex Inc. and Integrated Genetics. From 1975 to 1980, he served in several positions for Baxter Travenol Laboratories ultimately attaining the position of President, Fenwal Division at Baxter International Inc. Mr. Carpenter served as the Chief Executive Officer at Hydra Biosciences, Inc. from November 1991 to December 2000. Mr. Carpenter served as Chairman at GelTex Pharmaceuticals, Inc. since 1991. He serves as Chairman at Hydra Biosciences, Inc. Mr. Carpenter serves as Director at Good Start Genetics, Inc. and SynapDx Corporation. He served as Director at Moderna Therapeutics, Inc. Mr. Carpenter served as Trustee of Immune Disease Institute, Inc. He served as a Director of Cardiac Science Inc. since August 2000 until his resignation on September 17, 2003. Mr. Carpenter served as a Director at Peptimmune, Inc. He served as a Director of Genzyme Oncology, Inc. since 1994 until 2011 and its Lead Director. Mr. Carpenter served as a Director of GelTex Pharmaceuticals, Inc. since 1991. Mr. Carpenter served as a Director of Aquila Biopharmaceuticals, Inc. since 1998 and Genzyme Surgical Products. He served as a Director at Genzyme Tissue Repair, Genzyme General and Sanofi Biosurgery Inc. since 1994. Mr. Carpenter received a BS in engineering from the United States Military Academy at West Point in 1967, an M.S. in Computer Science from Stanford University in 1969 and an M.B.A. from Harvard Business School in 1975.
Positions
- Company NameImmuneering CorporationStock CodeIMRXPositionCo-Founder & Chair Emeritus
